Do People with Familial Mediterranean Fever Get Better?
Labels Familial Mediterranean Fever
FMF is a difficult disease to live with due to its recurrent, painful, and
disruptive nature. Patients who are not receiving colchicine therapy may
develop kidney failure and die before the age of 50. If amyloidosis is a
complication, the risk for renal failure is greater and death by the age
of 50 is more likely. Daily therapy with colchicine greatly improves the
chance of survival. Individuals with FMF on colchicine may have a normal
lifespan if therapy is initiated before the development of excessive protein
for the kidneys to filter and before kidney damage occurs.
disruptive nature. Patients who are not receiving colchicine therapy may
develop kidney failure and die before the age of 50. If amyloidosis is a
complication, the risk for renal failure is greater and death by the age
of 50 is more likely. Daily therapy with colchicine greatly improves the
chance of survival. Individuals with FMF on colchicine may have a normal
lifespan if therapy is initiated before the development of excessive protein
for the kidneys to filter and before kidney damage occurs.
0 Response to "Do People with Familial Mediterranean Fever Get Better?"
Post a Comment